Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05911620

Evaluation of the Severity of Hepatic Fibrosis by Magnetic Resonance Elastography in the Diagnosis of Endogenous Hypercorticism

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
21 (estimated)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The main hypothesis of the HEPACORT study is that upon diagnosis of endogenous Cushing's syndrome, significant liver fibrosis may be present, particularly in the most severe forms of Cushing's syndrome. the HEPACORT study is the first exploratory study to assess the severity of liver fibrosis in patients with Cushing's syndrome or suspected of presenting by Magnetic Resonance Elastography (MRE).

Conditions

Interventions

TypeNameDescription
DEVICEMagnetic resonance elastography (MRE)Magnetic Resonance Imaging (MRI) imaging with low-frequency vibrations to create a visual map (elastogram) that shows stiffness of body tissues

Timeline

Start date
2023-10-24
Primary completion
2026-02-28
Completion
2026-08-31
First posted
2023-06-22
Last updated
2023-10-25

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05911620. Inclusion in this directory is not an endorsement.